Search Results Search Sort by RelevanceMost Recent Original Research Jan 2022 Promoting Children’s Health Equity With Medical-Dental Integration Ana Zea, DDS, DrPH and Michelle Henshaw, DDS, MPH In 2015, a community health center in Boston, Massachusetts, implemented a model of interdisciplinary care in a nationwide pilot. AMA J Ethics. 2022;24(1):E33-40. doi: 10.1001/amajethics.2022.33. Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603. Policy Forum Feb 2020 How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions? Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Tobacco and e-cigarette marketing is largely unrestricted in low- and middle-income countries, a violation of children’s rights. AMA J Ethics. 2020;22(2):E135-146. doi: 10.1001/amajethics.2020.135. Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723. Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402. Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410. Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056. Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063. Policy Forum Sep 2022 Roles of Environmental Services Workers’ Wages and Status in Patient Safety David Sine, DBioethics and Lloyd Duplechan This article offers a risk management standpoint on environmental services as a mission-critical function of any health care organization. AMA J Ethics. 2022;24(9):E876-882. doi: 10.1001/amajethics.2022.876. Policy Forum Apr 2023 How Should We Improve How Medical and Veterinary Students Learn About Human and Nonhuman Animals? Zoe Griffiths, MA and Jeff Sebo, PhD There are 5 things every clinician should know about why environmental threats matter to human and nonhuman animals’ health. AMA J Ethics. 2023;25(4):E272-277. doi: 10.1001/amajethics.2023.272. Pagination Current page 1 Page 2 Page 3 Next page Next › Last page Last »
Original Research Jan 2022 Promoting Children’s Health Equity With Medical-Dental Integration Ana Zea, DDS, DrPH and Michelle Henshaw, DDS, MPH In 2015, a community health center in Boston, Massachusetts, implemented a model of interdisciplinary care in a nationwide pilot. AMA J Ethics. 2022;24(1):E33-40. doi: 10.1001/amajethics.2022.33.
Policy Forum Jul 2019 How Should Unaccompanied Minors in Immigration Detention Be Protected From Coercive Medical Practices? Giselle Malina Safeguards are urgently needed for assessments of what constitutes appropriate care for unaccompanied minors in US detention facilities. AMA J Ethics. 2019;21(7):E603-610. doi: 10.1001/amajethics.2019.603.
Policy Forum Feb 2020 How Should Global Tobacco Control Efforts Be Prioritized to Protect Children in Resource-Poor Regions? Stella Aguinaga Bialous, DrPH and Yvette van der Eijk, PhD Tobacco and e-cigarette marketing is largely unrestricted in low- and middle-income countries, a violation of children’s rights. AMA J Ethics. 2020;22(2):E135-146. doi: 10.1001/amajethics.2020.135.
Policy Forum Aug 2020 How Structural Violence, Prohibition, and Stigma Have Paralyzed North American Responses to Opioid Overdose Mark Tyndall, MD, ScD and Zoë Dodd, MES Driven by toxic, unpredictable, unregulated supply, drug overdose deaths are rampant. Policies that support the war on drugs have to change to be helpful. AMA J Ethics. 2020;22(8):E723-728. doi: 10.1001/amajethics.2020.723.
Policy Forum May 2022 What Should Dietary Supplement Oversight Look Like in the US? Elizabeth Richardson, MSc, Farzana Akkas, MSc, and Amy B. Cadwallader, PhD Statutory limitations prevent the FDA from effectively regulating dietary supplements and have generated numerous calls for reform. AMA J Ethics. 2022;24(5):E402-409. doi: 10.1001/amajethics.2022.402.
Policy Forum May 2022 Which Features of Dietary Supplement Industry, Product Trends, and Regulation Deserve Physicians’ Attention? Amy B. Cadwallader, PhD and AMA Council on Science and Public Health Illegal, fraudulent, adulterated, or improperly labeled products should be regarded as sources of possible clinical and ethical harm to patients. AMA J Ethics. 2022;24(5):E410-418. doi: 10.1001/amajethics.2022.410.
Policy Forum Nov 2022 If Patients Don’t Use Available Health Service Pricing Information, Is Transparency Still Important? Christopher Whaley, PhD and Austin Frakt, PhD Online tools intended to make health care purchasing resemble “consumerism” have had little effect on improving transparency for patients. AMA J Ethics. 2022;24(11):E1056-1062. doi: 10.1001/amajethics.2022.1056.
Policy Forum Nov 2022 Informed Consent as a Means of Acknowledging and Avoiding Financial Toxicity as Iatrogenic Harm Kevin Schulman, MD and Barak Richman, PhD, JD Negative health consequences from costly care are referred to as financial toxicity and should be included in informed consent discussions. AMA J Ethics. 2022;24(11):E1063-1068. doi: 10.1001/amajethics.2022.1063.
Policy Forum Sep 2022 Roles of Environmental Services Workers’ Wages and Status in Patient Safety David Sine, DBioethics and Lloyd Duplechan This article offers a risk management standpoint on environmental services as a mission-critical function of any health care organization. AMA J Ethics. 2022;24(9):E876-882. doi: 10.1001/amajethics.2022.876.
Policy Forum Apr 2023 How Should We Improve How Medical and Veterinary Students Learn About Human and Nonhuman Animals? Zoe Griffiths, MA and Jeff Sebo, PhD There are 5 things every clinician should know about why environmental threats matter to human and nonhuman animals’ health. AMA J Ethics. 2023;25(4):E272-277. doi: 10.1001/amajethics.2023.272.